Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gleolan for Tumor Visualization in Ovarian Cancer Surgery
NCT05804370Phase 3Recruiting
- Sponsor
- NX Development Corp.
- Start
- May 2024
- Primary completion
- Sep 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of 5-aminolevulinic acid in ovarian cancer, sponsored by NX Development Corp.. Started May 2024; status: recruiting.
02
Drugs
5-aminolevulinic acid
03
Conditions
ovarian cancer
Beyond the preview
Go deeper on NCT05804370.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05804370.